Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

A doctor has warned of the potential dangers of a 'game changing' diabetes drug which could rival the likes of Ozempic. The ...

NVO's first-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, especially ...

Eli Lilly misses first-quarter estimates for earnings but beats the same for sales. Mounjaro and Zepbound sales beat ...

Novo Nordisk's Ozempic has been shown to improve waking distance and quality of life in people with type 2 diabetes ... benefit with [semaglutide] in the form of a tablet." It has also been ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide, which ...

The SOUL trial showed that oral semaglutide was safe in patients with type 2 diabetes and atherosclerotic cardiovascular ...

Semaglutide, which is traditionally a treatment for type 2 diabetes, was given to participants who had been diagnosed with a life-threatening form of liver disease called metabolic dysfunction ...